Minolira Extended Release | Minocycline Hydrochloride Tablet Breastfeeding

It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Minolira Extended Release | Minocycline Hydrochloride Tablet is safe for baby while breastfed.

What is Minolira Extended Release | Minocycline Hydrochloride Tablet used for?


MINOLIRA is indicated to treat the inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. MINOLIRA is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. (1) Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, MINOLIRA should be used only as indicated [see Warnings and Precautions (5.13)]. Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, MINOLIRA should be used only as indicated [see Warnings and Precautions (5.13)].

Can I continue breastfeeding if I am using Minolira Extended Release | Minocycline Hydrochloride Tablet? How long does it stays in breast milk?

Minolira Extended Release | Minocycline Hydrochloride Tablet low risk for breastfeeding
Minolira Extended Release | Minocycline Hydrochloride Tablet contains only one active ingredient that is Minocycline. We have analyzed the usage of Minocycline in breastfeeding and our analysis suggest that Minocycline poses Low risk for infant while breastfeeding and hence Minolira Extended Release | Minocycline Hydrochloride Tablet itself shall be considered Low risk item for breastfeeding.

Minolira Extended Release | Minocycline Hydrochloride Tablet Breastfeeding Analsys


Minocycline while Breastfeeding

Low Risk

Although it is secreted into breast milk it has not been detected in infant’s blood because it forms non-absorbable chelate compounds with milk calcium. It is not convenient a prolonged use (more than 3-4 weeks) since damage on bone growth plates, teeth discoloration, or alteration of intestinal flora may occur. Breast secretion can be black in color. Be aware of the possibility of false negative results of bacterial cultures when the mother is on antibiotics.

Minolira Extended Release | Minocycline Hydrochloride Tablet Breastfeeding Analsys - 2


Minocycline while Breastfeeding

CAS Number: 10118-90-8

Many reviews state that tetracyclines are contraindicated during breastfeeding because of possible staining of infants' dental enamel or bone deposition of tetracyclines. However, a close examination of available literature indicates that there is not likely to be harm in short-term use of minocycline during lactation because milk levels are low and absorption by the infant is inhibited by the calcium in breastmilk. Short-term use of minocycline is acceptable in nursing mothers. As a theoretical precaution, avoid prolonged or repeat courses during nursing. Monitor the infant for rash and for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash). Black discoloration of breastmilk has been reported with minocycline.

Is Minolira Extended Release | Minocycline Hydrochloride Tablet safe while breastfeeding

What should I do if already breastfed my kid after using Minolira Extended Release | Minocycline Hydrochloride Tablet?

Minolira Extended Release | Minocycline Hydrochloride Tablet is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Minolira Extended Release | Minocycline Hydrochloride Tablet so you should inform him based on your convenience.


My health care provider has asked me to use Minolira Extended Release | Minocycline Hydrochloride Tablet, what to do?

Though Minolira Extended Release | Minocycline Hydrochloride Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Minolira Extended Release | Minocycline Hydrochloride Tablet, will my baby need extra monitoring?

Not much monitoring required while using Minolira Extended Release | Minocycline Hydrochloride Tablet


Who can I talk to if I have questions about usage of Minolira Extended Release | Minocycline Hydrochloride Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week